Duane D. Miller, Ph.D. - Publications

Affiliations: 
2009 University of Akron, Akron, OH, United States 
Area:
Chemical Engineering, Environmental Engineering, Climate Change

166 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Miller DD, Chuang SSC. The Effect of Electron-Donating Groups and Hydrogen Bonding on H2S Capture over Polyethylene Glycol/Amine Sites Journal of Physical Chemistry C. 120: 1147-1162. DOI: 10.1021/Acs.Jpcc.5B11796  1
2015 Pi M, Kapoor K, Wu Y, Ye R, Senogles SE, Nishimoto SK, Hwang DJ, Miller DD, Narayanan R, Smith JC, Baudry J, Quarles LD. Structural and Functional Evidence for Testosterone Activation of GPRC6A in Peripheral Tissues. Molecular Endocrinology (Baltimore, Md.). me20151161. PMID 26440882 DOI: 10.1210/Me.2015-1161  1
2015 Wang Q, Lin Z, Kim TK, Slominski AT, Miller DD, Li W. Total synthesis of biologically active 20S-hydroxyvitamin D3. Steroids. PMID 26433048 DOI: 10.1016/j.steroids.2015.09.009  1
2015 Banerjee S, Wang J, Pfeffer S, Ma D, Pfeffer LM, Patil SA, Li W, Miller DD. Design, Synthesis and Biological Evaluation of Novel 5H-Chromenopyridines as Potential Anti-Cancer Agents. Molecules (Basel, Switzerland). 20: 17152-17165. PMID 26393554 DOI: 10.3390/molecules200917152  1
2015 Deng W, Kimura Y, Gududuru V, Wu W, Balogh A, Szabo E, Thompson KE, Yates CR, Balazs L, Johnson LR, Miller DD, Strobos J, McCool WS, Tigyi GJ. Mitigation of the hematopoietic and gastrointestinal acute radiation syndrome by octadecenyl thiophosphate, a small molecule mimic of lysophosphatidic acid. Radiation Research. 183: 465-75. PMID 25807318 DOI: 10.1667/RR13830.1  1
2015 Miller DD, Chuang SSC. Experimental and theoretical investigation of SO2 adsorption over the 1,3-phenylenediamine/SiO2 system Journal of Physical Chemistry C. 119: 6713-6727. DOI: 10.1021/Acs.Jpcc.5B01131  1
2015 Miller DD, Siriwardane R, Poston J. Fluidized-bed and fixed-bed reactor testing of methane chemical looping combustion with MgO-promoted hematite Applied Energy. 146: 111-121. DOI: 10.1016/j.apenergy.2015.02.047  1
2014 McMillan JE, Bukiya AN, Terrell CL, Patil SA, Miller DD, Dopico AM, Parrill AL. Multi-generational pharmacophore modeling for ligands to the cholane steroid-recognition site in the β₁ modulatory subunit of the BKCa channel. Journal of Molecular Graphics & Modelling. 54: 174-83. PMID 25459769 DOI: 10.1016/J.Jmgm.2014.10.008  1
2014 Leblanc R, Lee SC, David M, Bordet JC, Norman DD, Patil R, Miller D, Sahay D, Ribeiro J, Clézardin P, Tigyi GJ, Peyruchaud O. Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone. Blood. 124: 3141-50. PMID 25277122 DOI: 10.1182/blood-2014-04-568683  1
2014 Jiang Y, Pagadala J, Miller DD, Steinle JJ. Insulin-like growth factor-1 binding protein 3 (IGFBP-3) promotes recovery from trauma-induced expression of inflammatory and apoptotic factors in retina. Cytokine. 70: 115-9. PMID 25082650 DOI: 10.1016/J.Cyto.2014.07.004  1
2014 Narayanan R, Ahn S, Cheney MD, Yepuru M, Miller DD, Steiner MS, Dalton JT. Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling. Plos One. 9: e103202. PMID 25072326 DOI: 10.1371/journal.pone.0103202  1
2014 Morales-Lázaro SL, Serrano-Flores B, Llorente I, Hernández-García E, González-Ramírez R, Banerjee S, Miller D, Gududuru V, Fells J, Norman D, Tigyi G, Escalante-Alcalde D, Rosenbaum T. Structural determinants of the transient receptor potential 1 (TRPV1) channel activation by phospholipid analogs. The Journal of Biological Chemistry. 289: 24079-90. PMID 25035428 DOI: 10.1074/Jbc.M114.572503  1
2014 Toutounchian JJ, Steinle JJ, Makena PS, Waters CM, Wilson MW, Haik BG, Miller DD, Yates CR. Modulation of radiation injury response in retinal endothelial cells by quinic acid derivative KZ-41 involves p38 MAPK. Plos One. 9: e100210. PMID 24956278 DOI: 10.1371/Journal.Pone.0100210  1
2014 Thompson KE, Zeng K, Wilson CM, Gaber MW, Miller DD, Yates CR. Quinic acid derivative KZ-41 exhibits radiomitigating activity in preclinical models of radiation injury. Drug Development Research. 75: 29-36. PMID 24648047 DOI: 10.1002/ddr.21164  1
2014 He H, Williams-Guy K, Pagadala J, Presley CS, Miller DD, Steinle JJ, Yates CR. A sensitive and fast LC-MS/MS method for determination of β-receptor agonist JP-49b: application to a pharmacokinetic study in rats. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 953: 86-91. PMID 24576769 DOI: 10.1016/J.Jchromb.2014.01.031  1
2014 Fells JI, Lee SC, Norman DD, Tsukahara R, Kirby JR, Nelson S, Seibel W, Papoian R, Patil R, Miller DD, Parrill AL, Pham TC, Baker DL, Bittman R, Tigyi G. Targeting the hydrophobic pocket of autotaxin with virtual screening of inhibitors identifies a common aromatic sulfonamide structural motif. The Febs Journal. 281: 1017-28. PMID 24314137 DOI: 10.1111/Febs.12674  1
2013 Slominski A, Kim TK, Zmijewski MA, Janjetovic Z, Li W, Chen J, Kusniatsova EI, Semak I, Postlethwaite A, Miller DD, Zjawiony JK, Tuckey RC. Novel vitamin D photoproducts and their precursors in the skin. Dermato-Endocrinology. 5: 7-19. PMID 24494038 DOI: 10.4161/derm.23938  1
2013 Zhang Q, Jiang Y, Toutounchian J, Wilson MW, Morales-Tirado V, Miller DD, Yates CR, Steinle JJ. Novel quinic acid derivative KZ-41 prevents retinal endothelial cell apoptosis without inhibiting retinoblastoma cell death through p38 signaling. Investigative Ophthalmology & Visual Science. 54: 5937-43. PMID 23942968 DOI: 10.1167/Iovs.13-12326  1
2013 Jiang Y, Liu L, Pagadala J, Miller DD, Steinle JJ. Compound 49b protects against blast-induced retinal injury. Journal of Neuroinflammation. 10: 96. PMID 23899290 DOI: 10.1186/1742-2094-10-96  1
2013 Fells JI, Lee SC, Fujiwara Y, Norman DD, Lim KG, Tsukahara R, Liu J, Patil R, Miller DD, Kirby RJ, Nelson S, Seibel W, Papoian R, Parrill AL, Baker DL, et al. Hits of a high-throughput screen identify the hydrophobic pocket of autotaxin/lysophospholipase D as an inhibitory surface. Molecular Pharmacology. 84: 415-24. PMID 23793291 DOI: 10.1124/Mol.113.087080  1
2013 Patil SA, Hosni-Ahmed A, Jones TS, Patil R, Pfeffer LM, Miller DD. Novel approaches to glioma drug design and drug screening. Expert Opinion On Drug Discovery. 8: 1135-51. PMID 23738794 DOI: 10.1517/17460441.2013.807248  1
2013 Bukiya AN, McMillan JE, Fedinec AL, Patil SA, Miller DD, Leffler CW, Parrill AL, Dopico AM. Cerebrovascular dilation via selective targeting of the cholane steroid-recognition site in the BK channel β1-subunit by a novel nonsteroidal agent. Molecular Pharmacology. 83: 1030-44. PMID 23455312 DOI: 10.1124/Mol.112.083519  1
2013 Monazam ER, Breault RW, Siriwardane R, Miller DD. Thermogravimetric analysis of modified hematite by methane (CH4) for chemical-looping combustion: A global kinetics mechanism Industrial and Engineering Chemistry Research. 52: 14808-14816. DOI: 10.1021/ie4024116  1
2013 Miller DD, Siriwardane R. Mechanism of methane chemical looping combustion with hematite promoted with CeO2 Energy and Fuels. 27: 4087-4096. DOI: 10.1021/ef302132e  1
2012 Kiss GN, Fells JI, Gupte R, Lee SC, Liu J, Nusser N, Lim KG, Ray RM, Lin FT, Parrill AL, Sümegi B, Miller DD, Tigyi G. Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions. Molecular Pharmacology. 82: 1162-73. PMID 22968304 DOI: 10.1124/Mol.112.079699  1
2012 Bukiya AN, Patil SA, Li W, Miller DD, Dopico AM. Calcium- and voltage-gated potassium (BK) channel activators in the 5β-cholanic acid-3α-ol analogue series with modifications in the lateral chain. Chemmedchem. 7: 1784-92. PMID 22945504 DOI: 10.1002/cmdc.201200290  1
2012 Mohler ML, Coss CC, Duke CB, Patil SA, Miller DD, Dalton JT. Androgen receptor antagonists: a patent review (2008-2011). Expert Opinion On Therapeutic Patents. 22: 541-65. PMID 22583332 DOI: 10.1517/13543776.2012.682571  1
2012 Zhang Q, Guy K, Pagadala J, Jiang Y, Walker RJ, Liu L, Soderland C, Kern TS, Ferry R, He H, Yates CR, Miller DD, Steinle JJ. Compound 49b prevents diabetes-induced apoptosis through increased IGFBP-3 levels. Investigative Ophthalmology & Visual Science. 53: 3004-13. PMID 22467575 DOI: 10.1167/Iovs.11-8779  1
2012 Danquah M, Duke CB, Patil R, Miller DD, Mahato RI. Combination therapy of antiandrogen and XIAP inhibitor for treating advanced prostate cancer. Pharmaceutical Research. 29: 2079-91. PMID 22451249 DOI: 10.1007/s11095-012-0737-1  1
2012 Wang XD, Freeman NE, Patil R, Patil SA, Mitra S, Orr WE, Abner CW, Yates CR, Miller DD, Geisert EE. EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo. Anti-Cancer Drugs. 23: 494-504. PMID 22391460 DOI: 10.1097/Cad.0B013E328351Ee4F  1
2011 Zeng K, Thompson KE, Presley CS, Miller DD, Yates CR. Preclinical pharmacokinetics of the radiomitigator KZ-41 in rats. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 41: 1006-12. PMID 21864202 DOI: 10.3109/00498254.2011.603387  1
2011 Gupte R, Patil R, Liu J, Wang Y, Lee SC, Fujiwara Y, Fells J, Bolen AL, Emmons-Thompson K, Yates CR, Siddam A, Panupinthu N, Pham TC, Baker DL, Parrill AL, ... ... Miller DD, et al. Benzyl and naphthalene methylphosphonic acid inhibitors of autotaxin with anti-invasive and anti-metastatic activity. Chemmedchem. 6: 922-35. PMID 21465666 DOI: 10.1002/Cmdc.201000425  1
2011 Ahn S, Kearbey JD, Li CM, Duke CB, Miller DD, Dalton JT. Biotransformation of a novel antimitotic agent, I-387, by mouse, rat, dog, monkey, and human liver microsomes and in vivo pharmacokinetics in mice. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 636-43. PMID 21233217 DOI: 10.1124/dmd.110.036673  1
2011 Patil SA, Patil R, Miller DD. Microwave-assisted synthesis of medicinally relevant indoles Current Medicinal Chemistry. 18: 615-637. PMID 21143107 DOI: 10.2174/092986711794480195  1
2011 Zmijewski MA, Li W, Chen J, Kim TK, Zjawiony JK, Sweatman TW, Miller DD, Slominski AT. Synthesis and photochemical transformation of 3β,21-dihydroxypregna-5,7-dien-20-one to novel secosteroids that show anti-melanoma activity. Steroids. 76: 193-203. PMID 21070794 DOI: 10.1016/J.Steroids.2010.10.009  1
2011 Ahn S, Hwang DJ, Barrett CM, Yang J, Duke CB, Miller DD, Dalton JT. A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer. Cancer Chemotherapy and Pharmacology. 67: 293-304. PMID 20383708 DOI: 10.1007/s00280-010-1319-8  1
2011 Pagadala J, Williams-Guy K, Nooh MM, Steinle JJ, Miller DD. Beta-adrenergic receptor signaling by the isomers of isoproterenol and like drugs in retinal endothelial cells and Müller cells Medchemcomm. 2: 726-730. DOI: 10.1039/C0Md00227E  1
2011 Miller DD, Siriwardane R, Simonyi T. Theoretical and experimental analysis of oxygen separation from air over Ni-transition metal complexes Energy and Fuels. 25: 4261-4270. DOI: 10.1021/ef200779m  1
2011 Patil R, Patil S, Wang X, Ma F, Orr WE, Li W, Yates CR, Geisert EE, Miller DD. Synthesis and evaluation of new 1,2,3,4-tetrahydroisoquinoline analogs as antiglioma agents Medicinal Chemistry Research. 20: 131-137. DOI: 10.1007/S00044-010-9356-8  1
2011 Miller DD, Siriwardane R, Simonyi T. Effect of additives on the decomposition of calcium carbonate for sorbent enhanced steam methane reforming, Sorbent Regeneration 28th Annual International Pittsburgh Coal Conference 2011, Pcc 2011. 2: 938-944.  1
2010 Ahn S, Duke CB, Barrett CM, Hwang DJ, Li CM, Miller DD, Dalton JT. I-387, a novel antimitotic indole, displays a potent in vitro and in vivo antitumor activity with less neurotoxicity. Molecular Cancer Therapeutics. 9: 2859-68. PMID 20829196 DOI: 10.1158/1535-7163.MCT-10-0399  1
2010 Nassr M, Wang X, Mitra S, Freeman-Anderson NE, Patil R, Yates CR, Miller DD, Geisert EE. Treating retinoblastoma in tissue culture and in a rat model with a novel isoquinoline derivative. Investigative Ophthalmology & Visual Science. 51: 3813-9. PMID 20570997 DOI: 10.1167/Iovs.09-5042  1
2010 Jones A, Hwang DJ, Duke CB, He Y, Siddam A, Miller DD, Dalton JT. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation. The Journal of Pharmacology and Experimental Therapeutics. 334: 439-48. PMID 20444881 DOI: 10.1124/jpet.110.168880  1
2010 Slominski AT, Janjetovic Z, Fuller BE, Zmijewski MA, Tuckey RC, Nguyen MN, Sweatman T, Li W, Zjawiony J, Miller D, Chen TC, Lozanski G, Holick MF. Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity. Plos One. 5: e9907. PMID 20360850 DOI: 10.1371/Journal.Pone.0009907  1
2010 Narayanan R, Yepuru M, Szafran AT, Szwarc M, Bohl CE, Young NL, Miller DD, Mancini MA, Dalton JT. Discovery and mechanistic characterization of a novel selective nuclear androgen receptor exporter for the treatment of prostate cancer. Cancer Research. 70: 842-51. PMID 20068182 DOI: 10.1158/0008-5472.CAN-09-3206  1
2010 Siriwardane R, Tian H, Miller D, Richards G, Simonyi T, Poston J. Evaluation of reaction mechanism of coal-metal oxide interactions in chemical-looping combustion Combustion and Flame. 157: 2198-2208. DOI: 10.1016/J.Combustflame.2010.06.008  1
2009 Danquah M, Li F, Duke CB, Miller DD, Mahato RI. Micellar delivery of bicalutamide and embelin for treating prostate cancer. Pharmaceutical Research. 26: 2081-92. PMID 19415464 DOI: 10.1007/s11095-009-9903-5  1
2009 Ramagiri S, Ma F, Kosanam H, Wang X, Patil R, Miller DD, Geisert E, Yates CR. Fast and sensitive liquid chromatography/electrospray mass spectrometry method to study ocular penetration of EDL-155, a novel antitumor agent for retinoblastoma in rats Journal of Mass Spectrometry. 44: 786-793. PMID 19160451 DOI: 10.1002/Jms.1556  1
2009 Li W, Hwang DJ, Cremer D, Joo H, Kraka E, Kim J, Ross CR, Nguyen VQ, Dalton JT, Miller DD. Structure determination of chiral sulfoxide in diastereomeric bicalutamide derivatives. Chirality. 21: 578-83. PMID 18726944 DOI: 10.1002/Chir.20642  1
2009 Miller DD, Chuang SSC. Pulse transient responses of NO decomposition and reduction with H 2 on Ag-Pd/Al2O3 Journal of Physical Chemistry C. 113: 14963-14971. DOI: 10.1021/Jp904538T  1
2009 Miller DD, Chuang SSC. In situ infrared study of NO reduction over Pd/Al2O3 and Ag-Pd/Al2O3 catalysts under H2-rich and lean-burn conditions Journal of the Taiwan Institute of Chemical Engineers. 40: 613-621. DOI: 10.1016/J.Jtice.2009.04.006  1
2009 Miller DD, Chuang SSC. The effect of O2 on the NO-CO reaction over Ag-Pd/Al2O3: An in situ infrared study Catalysis Communications. 10: 1313-1318. DOI: 10.1016/J.Catcom.2009.02.011  1
2008 Zmijewski MA, Li W, Zjawiony JK, Sweatman TW, Chen J, Miller DD, Slominski AT. Synthesis and photo-conversion of androsta- and pregna-5,7-dienes to vitamin D3-like derivatives. Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. 7: 1570-6. PMID 19037511 DOI: 10.1039/B809005J  1
2008 DeCuypere M, Lu Y, Miller DD, LeDoux MS. Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson's disease brain. Journal of Neurochemistry. 107: 1398-413. PMID 19013830 DOI: 10.1111/J.1471-4159.2008.05709.X  1
2008 Kang GS, Wang XD, Mohler ML, Kirichenko OV, Patil R, Orr WE, Miller DD, Geisert EE. Effects, in an in-vivo model system, of 1,2,3,4-tetrahydroisoquinoline on glioma. Anti-Cancer Drugs. 19: 859-70. PMID 18766000 DOI: 10.1097/Cad.0B013E32830D5887  1
2008 Bavadekar SA, Hong SS, Lee SI, Miller DD, Feller DR. Bioisosteric phentolamine analogs as selective human alpha(2)- versus alpha(1)-adrenoceptor ligands. European Journal of Pharmacology. 590: 53-60. PMID 18589415 DOI: 10.1016/J.Ejphar.2008.05.027  1
2008 Patil S, Bukiya AN, Li W, Dopico AM, Miller D. Design and synthesis of hydroxy-alkynoic acids and their methyl esters as novel activators of BK channels Bioorganic and Medicinal Chemistry Letters. 18: 3427-3430. PMID 18462939 DOI: 10.1016/j.bmcl.2008.03.080  1
2008 DeCuypere M, Kalabokis VN, Hao R, Schroeder D, Miller DD, LeDoux MS. Localization of N-methyl-norsalsolinol within rodent and human brain. Journal of Neuroscience Research. 86: 2543-52. PMID 18438936 DOI: 10.1002/Jnr.21691  1
2008 Tuckey RC, Li W, Zjawiony JK, Zmijewski MA, Nguyen MN, Sweatman T, Miller D, Slominski A. Pathways and products for the metabolism of vitamin D3 by cytochrome P450scc. The Febs Journal. 275: 2585-96. PMID 18410379 DOI: 10.1111/J.1742-4658.2008.06406.X  1
2008 Song P, Ma F, Wang F, Wang X, Patil R, Ramagiri S, Orr WE, Miller DD, Geisert E, Yates CR. Plasma and cerebrospinal fluid pharmacokinetics of the novel tetrahydroisoquinoline EDL-155 in rats Cancer Chemotherapy and Pharmacology. 61: 1037-1044. PMID 17768626 DOI: 10.1007/S00280-007-0563-Z  1
2008 Patil SA, Patil R, Miller DD. Synthetic applications of the nenitzescu reaction to biologically active 5-hydroxyindoles Current Organic Chemistry. 12: 691-717. DOI: 10.2174/138527208784567223  1
2007 Deng W, Shuyu E, Tsukahara R, Valentine WJ, Durgam G, Gududuru V, Balazs L, Manickam V, Arsura M, VanMiddlesworth L, Johnson LR, Parrill AL, Miller DD, Tigyi G. The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology. 132: 1834-51. PMID 17484878 DOI: 10.1053/J.Gastro.2007.03.038  1
2007 Bohl CE, Wu Z, Miller DD, Bell CE, Dalton JT. Crystal structure of the T877A human androgen receptor ligand-binding domain complexed to cyproterone acetate provides insight for ligand-induced conformational changes and structure-based drug design. The Journal of Biological Chemistry. 282: 13648-55. PMID 17311914 DOI: 10.1074/jbc.M611711200  1
2006 Patil R, Li W, Ross CR, Kraka E, Cremer D, Mohler ML, Dalton JT, Miller DD. Cesium fluoride and tetra-n-butylammonium fluoride mediated 1,4-N-->O shift of disubstituted phenyl ring of a bicalutamide derivative. Tetrahedron Letters. 47: 3941-3944. PMID 18079983 DOI: 10.1016/J.Tetlet.2006.03.154  1
2006 Gourley DR, Rowell C, Wingate L, Yates CR, Gourley GK, Miller DD, Vleet V. Status of PharmD/PhD programs in colleges of pharmacy: the University of Tennessee dual PharmD/PhD program American Journal of Pharmaceutical Education. 70: 44. PMID 17149422 DOI: 10.5688/aj700244  1
2006 Mohler ML, Kang GS, Hong SS, Patil R, Kirichenko OV, Li W, Rakov IM, Geisert EE, Miller DD. Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues. Journal of Medicinal Chemistry. 49: 5845-8. PMID 16970409 DOI: 10.1021/Jm060020X  1
2006 Bavadekar SA, Ma G, Mustafa SM, Moore BM, Miller DD, Feller DR. Tethered yohimbine analogs as selective human alpha2C-adrenergic receptor ligands. The Journal of Pharmacology and Experimental Therapeutics. 319: 739-48. PMID 16873606 DOI: 10.1124/Jpet.106.105981  1
2006 Perera MA, Yin D, Wu D, Chan KK, Miller DD, Dalton J. In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 1713-21. PMID 16815963 DOI: 10.1124/dmd.106.009985  1
2006 Yang J, Bohl CE, Nair VA, Mustafa SM, Seoung SH, Miller DD, Dalton JT. Preclinical pharmacology of a nonsteroidal ligand for androgen receptor-mediated imaging of prostate cancer Journal of Pharmacology and Experimental Therapeutics. 317: 402-408. PMID 16434567 DOI: 10.1124/jpet.105.094334  1
2006 Nikulin VI, Rakov IM, De Los Angeles JE, Mehta RC, Boyd LY, Feller DR, Miller DD. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline-6,7-diols as novel affinity and photoaffinity probes for beta-adrenoceptor subtypes. Bioorganic & Medicinal Chemistry. 14: 1684-97. PMID 16431119 DOI: 10.1016/j.bmc.2005.12.027  1
2006 Wu D, Wu Z, Yang J, Nair VA, Miller DD, Dalton JT. Pharmacokinetics and metabolism of a selective androgen receptor modulator in rats: Implication of molecular properties and intensive metabolic profile to investigate ideal pharmacokinetic characteristics of a propanamide in preclinical study Drug Metabolism and Disposition. 34: 483-494. PMID 16381665 DOI: 10.1124/DMD.105.006643  1
2006 Durgam GG, Tsukahara R, Makarova N, Walker MD, Fujiwara Y, Pigg KR, Baker DL, Sardar VM, Parrill AL, Tigyi G, Miller DD. Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands. Bioorganic & Medicinal Chemistry Letters. 16: 633-40. PMID 16263282 DOI: 10.1016/J.Bmcl.2005.10.031  1
2006 Nair VA, Mustafa SM, Mohler ML, Dalton JT, Miller DD. Synthesis of oxazolidinedione derived bicalutamide analogs Tetrahedron Letters. 47: 3953-3955. DOI: 10.1016/j.tetlet.2006.03.146  1
2005 Hong SS, Bavadekar SA, Lee SI, Patil PN, Lalchandani SG, Feller DR, Miller DD. Bioisosteric phentolamine analogs as potent alpha-adrenergic antagonists. Bioorganic & Medicinal Chemistry Letters. 15: 4691-5. PMID 16153828 DOI: 10.1016/J.Bmcl.2005.07.083  1
2005 Bohl CE, Miller DD, Chen J, Bell CE, Dalton JT. Structural basis for accommodation of nonsteroidal ligands in the androgen receptor. The Journal of Biological Chemistry. 280: 37747-54. PMID 16129672 DOI: 10.1074/jbc.M507464200  1
2005 Mustafa SM, Bavadekar SA, Ma G, Moore BM, Feller DR, Miller DD. Synthesis and biological studies of yohimbine derivatives on human alpha2C-adrenergic receptors. Bioorganic & Medicinal Chemistry Letters. 15: 2758-60. PMID 15911252 DOI: 10.1016/J.Bmcl.2005.03.116  1
2005 Bohl CE, Gao W, Miller DD, Bell CE, Dalton JT. Structural basis for antagonism and resistance of bicalutamide in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 102: 6201-6. PMID 15833816 DOI: 10.1073/pnas.0500381102  1
2005 Narang AS, Thoma L, Miller DD, Mahato RI. Cationic lipids with increased DNA binding affinity for nonviral gene transfer in dividing and nondividing cells. Bioconjugate Chemistry. 16: 156-68. PMID 15656587 DOI: 10.1021/bc049818q  1
2005 Mohler ML, Nair VA, Hwang DJ, Rakov IM, Patil R, Miller DD. Nonsteroidal tissue selective androgen receptor modulators: A promising class of clinical candidates Expert Opinion On Therapeutic Patents. 15: 1565-1585. DOI: 10.1517/13543776.15.11.1565  1
2004 Gao W, Kearbey JD, Nair VA, Chung K, Parlow AF, Miller DD, Dalton JT. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5α-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: New approach for benign prostate hyperplasia Endocrinology. 145: 5420-5428. PMID 15308613 DOI: 10.1210/en.2004-0627  1
2004 Lalchandani SG, Zhang X, Hong SS, Liggett SB, Li W, Moore BM, Miller DD, Feller DR. Medetomidine analogs as selective agonists for the human alpha2-adrenoceptors. Biochemical Pharmacology. 67: 87-96. PMID 14667931 DOI: 10.1016/J.Bcp.2003.08.043  1
2004 Nair VA, Mustafa SM, Mohler ML, Fisher SJ, Dalton JT, Miller DD. Synthesis of novel iodo derived bicalutamide analogs Tetrahedron Letters. 45: 9475-9477. DOI: 10.1016/j.tetlet.2004.10.130  1
2003 Mahato RI, Narang AS, Thoma L, Miller DD. Emerging trends in oral delivery of peptide and protein drugs. Critical Reviews in Therapeutic Drug Carrier Systems. 20: 153-214. PMID 14584523 DOI: 10.1615/CritRevTherDrugCarrierSyst.v20.i23.30  1
2003 Wagner CE, Mohler ML, Kang GS, Miller DD, Geisert EE, Chang YA, Fleischer EB, Shea KJ. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81. Journal of Medicinal Chemistry. 46: 2823-33. PMID 12825926 DOI: 10.1021/Jm020326D  1
2003 Virag T, Elrod DB, Liliom K, Sardar VM, Parrill AL, Yokoyama K, Durgam G, Deng W, Miller DD, Tigyi G. Fatty alcohol phosphates are subtype-selective agonists and antagonists of lysophosphatidic acid receptors. Molecular Pharmacology. 63: 1032-42. PMID 12695531 DOI: 10.1124/Mol.63.5.1032  1
2003 Yin D, He Y, Perera MA, Hong SS, Marhefka C, Stourman N, Kirkovsky L, Miller DD, Dalton JT. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Molecular Pharmacology. 63: 211-23. PMID 12488554 DOI: 10.1124/mol.63.1.211  1
2002 Lalchandani SG, Lei L, Zheng W, Suni MM, Moore BM, Liggett SB, Miller DD, Feller DR. Yohimbine dimers exhibiting selectivity for the human alpha 2C-adrenoceptor subtype. The Journal of Pharmacology and Experimental Therapeutics. 303: 979-84. PMID 12438517 DOI: 10.1124/Jpet.102.039057  1
2001 Marhefka CA, Moore BM, Bishop TC, Kirkovsky L, Mukherjee A, Dalton JT, Miller DD. Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands Journal of Medicinal Chemistry. 44: 1729-1740. PMID 11356108 DOI: 10.1021/jm0005353  1
2001 Liliom K, Sun G, Bünemann M, Virág T, Nusser N, Baker DL, Wang DA, Fabian MJ, Brandts B, Bender K, Eickel A, Malik KU, Miller DD, Desiderio DM, Tigyi G, et al. Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors. The Biochemical Journal. 355: 189-97. PMID 11256963 DOI: 10.1042/0264-6021:3550189  1
2001 Konkar AA, Nikulin VI, De Los Angeles J, Hong SS, Fertel RH, Miller DD, Feller DR. Biochemical activities of trimetoquinol analogs at human beta(1)- and beta(3)-adrenergic receptors. Pharmacology. 62: 45-55. PMID 11150922 DOI: 10.1159/000056071  1
2000 Liliom K, Bünemann M, Sun G, Miller D, Desiderio DM, Brandts B, Bender K, Pott L, Nusser N, Tigyi G. Sphingosylphosphorylcholine is a bona fide mediator regulating heart rate. Annals of the New York Academy of Sciences. 905: 308-10. PMID 10818471 DOI: 10.1111/J.1749-6632.2000.Tb06567.X  1
2000 Zheng W, Lei L, Lalchandani S, Sun G, Feller DR, Miller DD. Yohimbine dimers exhibiting binding selectivities for human alpha2a- versus alpha2b-adrenergic receptors. Bioorganic & Medicinal Chemistry Letters. 10: 627-30. PMID 10762040 DOI: 10.1016/S0960-894X(00)00068-8  1
2000 He Y, Nikulin VI, Vansal SS, Feller DR, Miller DD. Synthesis and human beta-adrenoceptor activity of 1-(3,5-diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol derivatives in vitro. Journal of Medicinal Chemistry. 43: 591-8. PMID 10691685 DOI: 10.1021/jm990463j  1
2000 Zheng X, Donkor IO, Miller DD, Ross CR. Unprecedented crystallization and X-ray crystal structure of racemic N(α)-(t-butyloxycarbonyl)-L-phenylalanine N-methoxy-N-methylamide Chirality. 12: 2-6. PMID 10602260 DOI: 10.1002/(SICI)1520-636X(2000)12:1<2::AID-CHIR2>3.0.CO;2-Y  1
1999 Tigyi G, Fisher DJ, Lilion K, Guo Z, Virag T, Sun G, Miller DD, Murakami-Murofushi K, Kobayashi S, Erickson JR. Determinants of receptor subtype specificity in the LPA-like lipid mediator family. Advances in Experimental Medicine and Biology. 469: 245-51. PMID 10667337 DOI: 10.1007/978-1-4615-4793-8_36  1
1999 Zheng W, Nikulin VI, Konkar AA, Vansal SS, Shams G, Feller DR, Miller DD. 2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: novel selective beta3-adrenoceptor agonists. Journal of Medicinal Chemistry. 42: 2287-94. PMID 10377236 DOI: 10.1021/jm990012z  1
1998 Liliom K, Fischer DJ, Virág T, Sun G, Miller DD, Tseng JL, Desiderio DM, Seidel MC, Erickson JR, Tigyi G. Identification of a novel growth factor-like lipid, 1-O-cis-alk-1'-enyl-2-lyso-sn-glycero-3-phosphate (alkenyl-GP) that is present in commercial sphingolipid preparations. The Journal of Biological Chemistry. 273: 13461-8. PMID 9593679 DOI: 10.1074/Jbc.273.22.13461  1
1998 Lei L, Vaghy PL, Slavica M, De Los Angeles J, Smith B, Miller DD, Feller DR. Activation of L-type calcium channel by tolazoline derivatives: role of isothiocyanate moiety. Journal of Cardiovascular Pharmacology. 31: 721-33. PMID 9593072 DOI: 10.1097/00005344-199805000-00011  1
1998 Sun G, Slavica M, Uretsky NJ, Wallace LJ, Shams G, Weinstein DM, Miller JC, Miller DD. Design and synthesis of enantiomers of 3,5-dinitro-o-tyrosine: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonists. Journal of Medicinal Chemistry. 41: 1034-41. PMID 9544203 DOI: 10.1021/Jm970276Q  1
1997 Hill RA, Wallace LJ, Miller DD, Weinstein DM, Shams G, Tai H, Layer RT, Willins D, Uretsky NJ, Danthi SN. Structure--activity studies for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptors: acidic hydroxyphenylalanines. Journal of Medicinal Chemistry. 40: 3182-91. PMID 9379437 DOI: 10.1021/Jm950028Z  1
1997 Zhang X, De Los Angeles JE, He MY, Dalton JT, Shams G, Lei L, Patil PN, Feller DR, Miller DD, Hsu FL. Medetomidine analogs as alpha 2-adrenergic ligands. 3. Synthesis and biological evaluation of a new series of medetomidine analogs and their potential binding interactions with alpha 2-adrenoceptors involving a "methyl pocket". Journal of Medicinal Chemistry. 40: 3014-24. PMID 9301663 DOI: 10.1021/Jm960642Q  1
1997 Christoff JJ, Bradley L, Miller DD, Lei L, Rodriguez F, Fraundorfer P, Romstedt K, Shams G, Feller DR. Synthesis and evaluation of trimetoquinol derivatives: novel thromboxane A2/prostaglandin H2 antagonists with diminished beta-adrenergic agonist activity. Journal of Medicinal Chemistry. 40: 85-91. PMID 9016331 DOI: 10.1021/jm950896w  1
1997 Shams G, Romstedt KJ, Lust LA, Clark MT, Miller DD, Feller DR. Beta-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs. General Pharmacology. 28: 323-30. PMID 9013212 DOI: 10.1016/S0306-3623(96)00223-6  1
1996 Bünemann M, Liliom K, Brandts BK, Pott L, Tseng JL, Desiderio DM, Sun G, Miller D, Tigyi G. A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1-phosphate in atrial myocytes. The Embo Journal. 15: 5527-34. PMID 8896446 DOI: 10.1002/J.1460-2075.1996.Tb00937.X  1
1996 Sun G, Uretsky NJ, Wallace LJ, Shams G, Weinstein DM, Miller DD. Synthesis of chiral 1-(2'-amino-2'-carboxyethyl)-1,4-dihydro-6,7-quinoxaline-2,3-diones: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor agonists and antagonists. Journal of Medicinal Chemistry. 39: 4430-8. PMID 8893837 DOI: 10.1021/Jm950632+  1
1996 Lezama EJ, Konkar AA, Salazar-Bookaman MM, Miller DD, Feller DR. Pharmacological study of atypical beta-adrenoceptors in rat esophageal smooth muscle. European Journal of Pharmacology. 308: 69-80. PMID 8836634 DOI: 10.1016/0014-2999(96)00236-1  1
1996 Konkar AA, Fraundorfer PF, Fertel RH, Burkman AM, Miller DD, Feller DR. Pharmacological activities of trimetoquinol and 1-benzyl halogen-substituted analogues on rat beta-adrenoceptor subtypes. European Journal of Pharmacology. 305: 63-71. PMID 8813533 DOI: 10.1016/0014-2999(96)00034-9  1
1996 De Los Angeles JE, Nikulin VI, Shams G, Konkar AA, Mehta R, Feller DR, Miller DD. Iodinated analogs of trimetoquinol as highly potent and selective beta 2-adrenoceptor ligands. Journal of Medicinal Chemistry. 39: 3701-11. PMID 8809159 DOI: 10.1021/jm960208o  1
1996 Zhang X, Yao XT, Dalton JT, Shams G, Lei L, Patil PN, Feller DR, Hsu FL, George C, Miller DD. Medetomidine analogs as alpha 2-adrenergic ligands. 2. Design, synthesis, and biological activity of conformationally restricted naphthalene derivatives of medetomidine. Journal of Medicinal Chemistry. 39: 3001-13. PMID 8709134 DOI: 10.1021/jm9506074  1
1994 Slavica M, Lei L, Patil PN, Kerezy A, Feller DR, Miller DD. Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta. Journal of Medicinal Chemistry. 37: 1874-81. PMID 8021927 DOI: 10.1021/jm00038a017  1
1994 Hong SS, Romstedt KJ, Feller DR, Hsu FL, Cupps TL, Lyon RA, Miller DD. A structure-activity relationship study of benzylic modifications of 4-[1-(1-naphthyl)ethyl]-1H-imidazoles on alpha 1- and alpha 2-adrenergic receptors. Journal of Medicinal Chemistry. 37: 2328-33. PMID 7914537 DOI: 10.1021/jm00041a011  1
1994 Fraundorfer PF, Lezama EJ, Salazar-Bookaman MM, Fertel RH, Miller DD, Feller DR. Isomeric-activity ratios of trimetoquinol enantiomers on beta-adrenergic receptor subtypes: functional and biochemical studies. Chirality. 6: 76-85. PMID 7911313 DOI: 10.1002/chir.530060207  1
1994 Farooqui T, Brooks K, Harrold MW, Miller DD, Wallace LJ, Uretsky NJ. Interaction of permanently charged metoclopramide analogs with D-2 dopamine receptors. General Pharmacology. 25: 1577-84. PMID 7721031 DOI: 10.1016/0306-3623(94)90357-3  1
1993 Farooqui T, Markovich K, Wallace L, Miller D, Uretsky N. Interaction of AZA analogs of chlorpromazine with the dopamine D2 receptor General Pharmacology. 24: 147-151. PMID 8482489 DOI: 10.1016/0306-3623(93)90026-T  1
1993 Abdel-Ghany YS, Ihnat MA, Miller DD, Kunin CM, Tong HH. Structure-activity relationship of glycine betaine analogs on osmotolerance of enteric bacteria. Journal of Medicinal Chemistry. 36: 784-9. PMID 8459406  1
1993 Kunin CM, Tong HH, Miller DD, Abdel-Ghany Y, Poggi MC, LeRudulier D. Effect of novel compound, 1-methyl-1-piperidino methane sulfonate (MPMS), on the osmoprotectant activity of glycine betaine, choline and L-proline in Escherichia coli. Archives of Microbiology. 160: 81-6. PMID 8397499 DOI: 10.1007/BF00288707  1
1993 Romstedt KJ, Shin Y, Shams G, Doyle K, Tantishaiyakul V, Clark MT, Adejare A, Hamada A, Miller DD, Feller DR. Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta. Biochemical Pharmacology. 46: 2051-9. PMID 8267653 DOI: 10.1016/0006-2952(93)90647-F  1
1993 Markovich KM, Farooqui T, Wallace LJ, Uretsky NJ, Miller DD. Enhancement of binding of quaternary ammonium derivatives of chlorpromaxine to dopamine D-2 receptors by the addition of a H-bonding group Bioorganic and Medicinal Chemistry Letters. 3: 1241-1244. DOI: 10.1016/S0960-894X(00)80323-6  1
1992 Hong SS, Romstedt KJ, Feller DR, Hsu FL, George C, Cupps TL, Lyon RA, Miller DD. Resolution and adrenergic activities of the optical isomers of 4-[1-(1-naphthyl)ethyl]-1H-imidazole. Chirality. 4: 432-8. PMID 1361151 DOI: 10.1002/chir.530040706  1
1992 Amemiya Y, Hong SS, Venkataraman BV, Patil PN, Shams G, Romstedt K, Feller DR, Hsu FL, Miller DD. Synthesis and alpha-adrenergic activities of 2- and 4-substituted imidazoline and imidazole analogues. Journal of Medicinal Chemistry. 35: 750-5. PMID 1347319 DOI: 10.1021/jm00082a017  1
1992 Markovich KM, Tantishaiyakul V, Hamada A, Miller DD, Romstedt KJ, Shams G, Shin Y, Fraundorfer PF, Doyle K, Feller DR. Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activities. Journal of Medicinal Chemistry. 35: 466-79. PMID 1346651 DOI: 10.1021/Jm00081A007  1
1992 Esbenshade TA, Hamada A, Miller DD, Feller DR. Effects of the stereochemical orientation of phenethylamines and imidazolines on alpha-adrenergic receptor-mediated DNA synthesis in primary cultured rat hepatocytes. Chirality. 4: 279-85. PMID 1323987 DOI: 10.1002/chir.530040504  1
1991 Shin Y, Romstedt KJ, Doyle K, Harrold MW, Gerhardt MA, Miller DD, Patil PN, Feller DR. Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo Chirality. 3: 112-117. PMID 1830752 DOI: 10.1002/chir.530030206  1
1991 Shams G, Fedyna J, Romstedt KJ, Adejare A, Miller DD, Roche VF, Feller DR. Pharmacological properties of novel bicyclic isoquinoline analogs in isolated guinea pig atria, trachea and in human platelets: Relationship to trimetoquinol General Pharmacology. 22: 1155-1163. PMID 1687397 DOI: 10.1016/0306-3623(91)90595-W  1
1991 Shams G, Venkataraman BV, Hamada A, Miller DD, Patil PN, Feller DR. Diversity of the pharmacological actions of some tolazoline analogues in human platelets and rat aorta. European Journal of Pharmacology. 199: 315-23. PMID 1655482 DOI: 10.1016/0014-2999(91)90495-C  1
1990 Ahn Ch, Shams G, Schotzinger RL, Miller DD, Feller DR. Stereostructure Activity Relationships of Catecholamines on Human Platelet Function Proceedings of the Society For Experimental Biology and Medicine. 194: 149-156. PMID 2190233 DOI: 10.3181/00379727-194-43071  1
1990 Miller DD, Hamada A, Clark MT, Adejare A, Patil PN, Shams G, Romstedt KJ, Kim SU, Intrasuksri U, McKenzie JL. Synthesis and alpha 2-adrenoceptor effects of substituted catecholimidazoline and catecholimidazole analogues in human platelets. Journal of Medicinal Chemistry. 33: 1138-44. PMID 2157007 DOI: 10.1021/jm00166a009  1
1990 Shams G, Wallace LJ, Miller DD, Feller DR. Effects of thromboxane a2 on thoracic aorta of young and old rats: Use of selective thromboxane receptor antagonists Pharmacology. 40: 27-32. PMID 2139513 DOI: 10.1159/000138635  1
1990 Shams G, Harrold MW, Grazyl B, Miller DD, Feller DR. Pharmacological evaluation of the β-adrenoceptor agonist properties of N-benzyl substituted trimetoquinol analogues European Journal of Pharmacology. 184: 251-256. PMID 1981872 DOI: 10.1016/0014-2999(90)90616-E  1
1990 Shams G, Romstedt KJ, Gerhardt MA, Harrold MW, Miller DD, Feller DR. Pharmacological evaluation of the β-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues European Journal of Pharmacology. 184: 21-31. PMID 1976530 DOI: 10.1016/0014-2999(90)90663-Q  1
1989 Wallace RA, Wallace L, Harrold M, Miller D, Uretsky NJ. Interaction of permanently charged chlorpromazine and dopamine analogs with the striatal D-1 dopaminergic receptor Biochemical Pharmacology. 38: 2019-2025. PMID 2525907 DOI: 10.1016/0006-2952(89)90502-9  1
1989 Harrold MW, Wallace RA, Farooqui T, Wallace LJ, Uretsky N, Miller DD. Synthesis and D2 dopaminergic activity of pyrrolidinium, tetrahydrothiophenium, and tetrahydrothiophene analogues of sulpiride Journal of Medicinal Chemistry. 32: 874-880. PMID 2522993 DOI: 10.1021/Jm00124A024  1
1989 Venkalaraman BV, Hamada A, Shams G, Miller DD, Feller DR, Paiil PN. Paradoxical effects of isothiocyanate analog of tolazoline on rat aorta and human platelets1 Journal of Vascular Research. 26: 335-346. DOI: 10.1159/000158784  1
1988 Harrold MW, Grajzl B, Shin Y, Romstedt KJ, Feller DR, Miller DD. Synthesis and thromboxane A2 antagonist activity of N-benzyltrimetoquinol analogues Journal of Medicinal Chemistry. 31: 1506-1512. PMID 3397988 DOI: 10.1021/jm00403a006  1
1988 Chang-Ho A, Romstedt KJ, Wallace LJ, Miller DD, Feller DR. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade Biochemical Pharmacology. 37: 3023-3033. PMID 3134894 DOI: 10.1016/0006-2952(88)90292-4  1
1988 Ahn CH, Wallace LJ, Miller DD, Feller DR. Use of [3h]trimetoquinol as a radioligand in human platelets: Interaction with putative endoperoxide/thromboxane A2 receptor sites Thrombosis Research. 50: 387-399. PMID 2969151 DOI: 10.1016/0049-3848(88)90268-X  1
1988 Wallace RA, Farooqui T, Wallace L, Ares J, Yu An C, Miller D, Uretsky N. Interaction of permanently uncharged dopamine analogs with the D-2 dopaminergic receptor Biochemical Pharmacology. 37: 2077-2084. PMID 2967702 DOI: 10.1016/0006-2952(88)90559-X  1
1988 Miller DD, Harroid M, Wallace RA, Wallace LJ, Uretsky NJ. Dopaminergic drugs in the cationic form interact with D2 dopamine receptors Trends in Pharmacological Sciences. 9: 282-284. PMID 2907954 DOI: 10.1016/0165-6147(88)90011-9  1
1987 Wallace RA, Farooqui T, Wallace L, Ares J, Yu An Chang, Miller D, Uretsky N. Interaction of permanently charged analogs of dopamine with the D-2 dopaminergic receptor Biochemical Pharmacology. 36: 3903-3910. PMID 2961340 DOI: 10.1016/0006-2952(87)90456-4  1
1987 Harrold MW, Chang YA, Wallace RA, Farooqui T, Wallace LJ, Uretsky N, Miller DD. Charged analogues of chlorpromazine as dopamine antagonists Journal of Medicinal Chemistry. 30: 1631-1635. PMID 2887659 DOI: 10.1021/Jm00392A019  1
1987 Fedyna JS, Adejare A, Miller DD, Feller DR. Pharmacological evaluation of the β-adrenoceptor agonist and thromboxane antagonist properties of N-substituted trimetoquinol analogues European Journal of Pharmacology. 135: 161-171. PMID 2884118 DOI: 10.1016/0014-2999(87)90608-X  1
1987 Clark MT, Adejare A, Shams G, Feller DR, Miller DD. 5-fluoro- and 8-fluorotrimetoquinol: selective beta 2-adrenoceptor agonists. Journal of Medicinal Chemistry. 30: 86-90. PMID 2879920 DOI: 10.1021/Jm00384A015  1
1986 Chang-Ho A, Hamada A, Miller DD, Feller DR. Alpha-adrenoceptor-mediated actions of optical isomers and desoxy analogs of catecholimidazoline and norepinephrine in human platelets: In vitro Biochemical Pharmacology. 35: 4095-4102. PMID 3022751 DOI: 10.1016/0006-2952(86)90034-1  1
1986 Adejare A, Miller DD, Fedyna JS, Ahn CH, Feller DR. Syntheses and β-adrenergic agonist and antiaggregatory properties of N-substituted trimetoquinol analogues Journal of Medicinal Chemistry. 29: 1603-1609. PMID 2875182 DOI: 10.1021/Jm00159A008  1
1986 Clark MT, Chang J, Navran SS, Huzoor-Akbar, Mukhopadhyay A, Amin H, Feller DR, Miller DD. Synthesis and investigation of the beta-adrenoceptor agonist and platelet antiaggregatory properties of 1,7,8-trisubstituted 2,3,4,5-tetrahydro-1H-2-benzazepine analogues of trimetoquinol. Journal of Medicinal Chemistry. 29: 181-5. PMID 2869145 DOI: 10.1021/jm00152a003  1
1985 Huzoor-Akbar, Mukhopadhyay A, Anderson KS, Navran SS, Romstedt K, Miller DD, Feller DR. Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses Biochemical Pharmacology. 34: 641-647. PMID 3156599 DOI: 10.1016/0006-2952(85)90258-8  1
1984 Navran SS, Romstedt K, Chang J, Miller DD, Feller DR, Huzoor-Akbar. Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: Inhibition by a selective inhibitor of phospholipase C Thrombosis Research. 33: 499-510. PMID 6372157 DOI: 10.1016/0049-3848(84)90015-X  1
1983 Mayo JR, Miller DD, Feller DR. Stereoselective inhibition of prostaglandin-induced calcium release from platelet membranes by trimetoquinol Biochemical Pharmacology. 32: 1952-1955. PMID 6882470 DOI: 10.1016/0006-2952(83)90066-7  1
1983 Miller DD, Hamada A, Craig EC, Christoph GG, Gallucci JC, Rice PJ, Banning JW, Patil PN. Optically active catecholimidazolines: A study of steric interactions at α-adrenoceptors Journal of Medicinal Chemistry. 26: 957-963. PMID 6306239 DOI: 10.1021/jm00361a005  1
1983 Ruffolo RR, Rice PJ, Patil PN, Hamada A, Miller DD. Differences in the applicability of the Easson-Stedman hypothesis to the α1- and α2-adrenergic effects of phenethylamines and imidazolines European Journal of Pharmacology. 86: 471-475. PMID 6299762 DOI: 10.1016/0014-2999(83)90199-1  1
1982 Huzoor-Akbar, Navran SS, Chang J, Miller DD, Feller DR. Investigation of the effects of phospholipase C on human platelets: evidence that aggregation induced by phospholipase C is independent of prostaglandin generation, released ADP and is modulated by cyclic AMP Thrombosis Research. 27: 405-417. PMID 6293114 DOI: 10.1016/0049-3848(82)90058-5  1
1982 Mukhopadhyay A, Sober DJ, Chang J, Slenn RT, Amin HM, Miller DD, Feller DR. Bronchoselective actions of a new series of trimetoquinol analogues European Journal of Pharmacology. 77: 209-219. PMID 6277666 DOI: 10.1016/0014-2999(82)90121-2  1
1982 Huzoor-Akbar, Navran SS, Miller DD, Feller DR. Antiplatelet actions of trimetoquinol isomers: evidence for inhibition of a prostaglandin-independent pathway of platelet aggregation Biochemical Pharmacology. 31: 886-889. PMID 6123325 DOI: 10.1016/0006-2952(82)90482-8  1
1981 Anderson K, Kuruvilla A, Uretsky N, Miller DD. Synthesis and pharmacological evaluation of sulfonium analogues of dopamine: nonclassical dopamine agonists Journal of Medicinal Chemistry. 24: 683-687. PMID 7252978 DOI: 10.1021/jm00138a008  1
1981 Mayo JR, Navran SS, Huzoor-Akbar, Miller DD, Feller DR. Stereo-dependent inhibition of human platelet function by the optical isomers of trimetoquinol Biochemical Pharmacology. 30: 2237-2241. PMID 7188564 DOI: 10.1016/0006-2952(81)90093-9  1
1981 Sober DJ, Chang J, Fowble JW, Mukhopadhyay A, Feller DR, Miller DD, Fairchild EH. Selective and potent beta 2-adrenoceptor agents within the tetrahydroisoquinoline class: effect of methyl substitution at the benzylic carbon of the 1-(3,4,5-trimethoxybenzyl) group of trimetoquinol. Journal of Medicinal Chemistry. 24: 970-4. PMID 6120236 DOI: 10.1021/jm00140a011  1
1980 Miller DD, Bossart JF, Mayo JR, Feller DR. Synthesis, β-adrenergic activity, and platelet antiaggregatory activity of a positional isomer of trimetoquinol: 1-(2′,4′,5′-trimethoxybenzyl)-6,7-dihydroxy-1,2,3,4- tetrahydroisoquinoline Journal of Medicinal Chemistry. 23: 331-333. PMID 6102607 DOI: 10.1021/jm00177a027  1
1979 Piascik MT, Piascik MF, Miller DD, Feller DR. 1-substituted tetrahydroisoquinoline analogs: Beta adrenoceptor blocking agents in the isolated perfused rabbit heart Life Sciences. 24: 2433-2439. PMID 39210 DOI: 10.1016/0024-3205(79)90452-1  1
1979 Piascik MT, Osei-Gyimah P, Miller DD, Feller DR. Beta-adrenoceptor blocking activity of 1-substituted trimetoquinol analogs Biochemical Pharmacology. 28: 1807-1810. PMID 38798 DOI: 10.1016/0006-2952(79)90546-X  1
1978 Osei-Gyimah P, Piascik MT, Fowble JW, Feller DR, Miller DD. Synthesis and β-adrenoceptor activity of the erythro and threo isomers of substituted α-hydroxytrimetoquinol Journal of Medicinal Chemistry. 21: 1173-1178. PMID 31479 DOI: 10.1021/jm00209a019  1
1978 Piascik MT, Osei-Gyimah P, Miller DD, Feller DR. Stereoselective interaction of tetrahydroisoquinolines in β-adrenoceptor systems European Journal of Pharmacology. 48: 393-401. PMID 25778 DOI: 10.1016/0014-2999(78)90166-8  1
1977 Miller DD, Osei-Gyimah P, Raman RV, Feller DR. Synthesis of 1-substituted analogues of trimetoquinol possessing differential and selective β-adrenergic properties Journal of Medicinal Chemistry. 20: 1502-1504. PMID 21293 DOI: 10.1021/jm00221a029  1
1975 Miller DD, Merritt WVP, Kador PF, Feller DR. Synthesis and biological actions of fragmented derivatives of tetrahydroisoquinolines Journal of Medicinal Chemistry. 18: 99-102. PMID 1109581 DOI: 10.1021/jm00235a021  1
1974 Rahwan RG, O'Neil PJ, Miller DD. Differential secretion of catecholamines and tetrahydroisoquinolines from the bovine adrenal medulla Life Sciences. 14: 1927-1938. PMID 4847795 DOI: 10.1016/0024-3205(74)90409-3  1
1974 Lee OS, Mears JA, Miller DD, Feller DR. Evaluation of the optical isomers of tetrahydroisoquinolines in rat adipose tissue and guinea pig aorta. European Journal of Pharmacology. 28: 225-9. PMID 4430326 DOI: 10.1016/0014-2999(74)90137-X  1
1971 Shonk RF, Miller DD, Feller DR. Influence of substituted tetrahydroisoquinolines and catecholamines on lipolysis, in vitro-II. Stereoselectivity Biochemical Pharmacology. 20: 3403-3412. PMID 5132887 DOI: 10.1016/0006-2952(71)90445-X  1
Show low-probability matches.